Dark Forest Capital Management LP Adaptive Biotechnologies Corp Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $233,377 - $388,501	46,031 New	46,031 $250,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $19 - $38	3 New	3 $0
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $1,841 - $5,259	-182 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $154,443 - $226,111	-6,136 Reduced 97.12%	182 $5,000
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $78,922 - $104,818	2,629 Added 71.27%	6,318 $215,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $118,859 - $164,492	3,689 New	3,689 $151,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.